(1) Background: Carbapenem-resistant Acinetobacter baumannii (CBRAB) and Pseudomonas aeruginosa (CBRPA) are critical and high-priority pathogens that require new therapeutic developments. Medicinal plants are valuable pharmaceutical resources. This study explored the anti-infective properties of Mayan plants, Bignonia potosina, and Thouinia paucidentata. (2) Methods: Plant parts were extracted using n-hexane, and their ability to inhibit bacterial growth and counteract resistance mechanisms and virulence factors in CBRAB and CBRPA was assessed. GC-MS analysis of the composition of the non-polar extracts and chemometric techniques correlated the phytoconstituents with anti-infective properties. (3) Results: Bignonia potosina liana and flower extracts exhibited potent antibacterial activity against A. baumannii strains (MIC 15.7 to 250 µg/mL) and moderate activity against P. aeruginosa strains (MIC 250 to 1000 µg/mL). Thouinia paucidentata leaf extract at 1000 µg/mL reduced imipenem MIC by 2048-fold for CBRAB, and B. potosina flower extract significantly inhibited A. baumannii catalase activity (at 62.5 µg/mL) and reduced P. aeruginosa pyocyanin production (at 1000 µg/mL). Chemometric analysis identified fatty acids, fatty acid amides, terpenes, and higher alkanes as contributors to their anti-infective properties. (4) Conclusions: This study highlights the potential of medicinal plants in the development of novel anti-infective therapies against CBRAB and CBRPA with various targets.
Introduction: Leukemia is among the most common types of cancer. Currently, the main anti-leukemia treatments have significant drawbacks, which has led to the search for new and better drugs, especially those developed from natural products. Objective: The aim of this work was to perform simple modifications to a lupane-type pentacyclic triterpene isolated from Phoradendron wattii , in order to generate new semi-synthetic analogues for their possible effect against a panel of leukemia cell lines. Methods: Simple structural modifications on the triterpene 3 α ,23- O -isopropylidenyl-3 α ,23-dihydroxylup-20(29)-en-28-oic acid ( T2 ) isolated from Phoradendron wattii were performed and evaluated against a panel of leukemia cell lines and normal mononuclear cells (MNC). In addition, molecular docking analysis was used to better understand the possible mechanism of action, employing key molecular targets used in the search for compounds with anti-leukemic activity (BCL-2 and EGFR). Results: Of the all derivatives synthetized ( T2a - T2f ), the compound ( T2e ), 3 α ,23-dihydroxy-30-oxolup-20(29)-en-28-ol, showed inhibition in leukemia cell lines (CCRF-CEM, REH, JURKAT, MOLT-4, and THP-1) and induction of death by apoptosis to different degrees. Moreover, it showed a minor cytotoxic effect on MNC and was found to interact with BCL-2 and EGFR in silico . Conclusion: The present work shows that simple modifications at promising sites in the lupane-type pentacyclic triterpene can generate derivatives with enhanced biological activity against leukemia cell lines. The T2e derivative is a promising candidate for future research.
Background: Infections caused by Staphylococcus aureus are a health problem worsened by antibiotic resistance. New drugs, including those inhibiting virulence and resistance mechanisms, are needed. This study aimed to evaluate the anti-growth, anti-virulence, and anti-biofilm activities of Trametes villosa. (2) Methods: Fractions were obtained from the basidiomata of T. villosa. Anti-growth, anti-hemolysis, and anti-biofilm activities were tested against S. aureus strains using resazurin microtiter, blood cell lysis, and crystal violet assays, respectively. Cytotoxicity was evaluated in Vero and HaCaT cells using sulforhodamine B. The active fractions were subjected to GC-MS analysis and molecular docking with S. aureus quorum-sensing receptors. Results: The n-hexane and ethyl acetate (EtOAc) fractions exhibited anti-growth activity against all strains (MIC: 31.2–2000 µg/mL). These fractions also displayed anti-hemolysis (IC50 = 33.8 ± 1.1–53.8 ± 5.1 µg/mL) and anti-biofilm formation activity (IC50 = 106.6 ± 4.8–383.4 ± 31.4 µg/mL), while exhibiting low cytotoxicity in Vero and HaCat. GC-MS analysis revealed that both active fractions mainly contained alkanes, aldehydes, and fatty acids. Molecular docking revealed that isovanillic acid, identified in the EtOAc fraction, exhibited optimal interactions with S. aureus quorum-sensing receptors AgrA and SarA. (4) Conclusions: Our research highlights the potential of T. villosa as a source of bioactive compounds effective against S. aureus.